No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
This company maintains a diverse business portfolio, encompassing the provision of medical services, pharmaceutical manufacturing, and the distribution of daily chemical and wellness products. Its pharmaceutical production includes various dosage forms such as tablets, syrups, capsules, mixtures, and pills. The enterprise was established on September 30, 2001, with its primary office situated in Beijing, China.
www.njhtg.comNo one on the platform currently holds 002219.SZ.
No tracked institution reports a position in 002219.SZ as of their last filing.
No one on the platform has traded 002219.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 1.2% | — | — | — | ||
| Rev. Growth % | -19.6% | 1.7% | ||||
| Profit Margin % | 1.0% | -0.5% | -8.5% | |||
| Free Cash Flow Margin % | 1.2% | |||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $3.4B | +1.5% | $0.02 | $0.02–$0.02 | — | 1 |
| 2027 | $3.8B | +11.6% | $0.03 | $0.03–$0.03 | — | 1 |
| 2028 | $4.2B | +10.9% | $0.03 | $0.03–$0.03 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 002219.SZNew Journey Health Technology Group Co.,LTD | $2.11 | +0.48% | $7.3B | — |
| 002390.SZGuizhou Xinbang Pharmaceutical Co., Ltd. | $2.93 | +0.69% | $5.7B | — |
| 002424.SZGuizhou Bailing Group Pharmaceutical Co., Ltd. | $4.44 | -0.22% | $6.2B | — |
| 002437.SZHarbin Gloria Pharmaceuticals Co., Ltd | $3.38 | +0.90% | $7.5B | — |
| 002907.SZChongqing Pharscin Pharmaceutical Co., Ltd. |
| $13.32 |
| -0.08% |
| $5.6B |
| — |
| 300158.SZShanxi Zhendong Pharmaceutical Co.,Ltd | $5.02 | +0.00% | $5.0B | — |
| 300267.SZHunan Er-Kang Pharmaceutical Co., Ltd | $3.16 | +1.94% | $6.5B | — |
Source: Financial Modeling Prep · peers by sector/industry